AFIP Archives - From the Archives of the AFIP

Lymphangioleiomyomatosis: Radiologic-Pathologic Correlation

Published Online:https://doi.org/10.1148/rg.253055006

Lymphangioleiomyomatosis (LAM) is an uncommon interstitial lung disease that exclusively affects women, usually during their reproductive years. LAM is characterized pathologically by abnormal proliferation of LAM cells in the lungs and in thoracic and retroperitoneal lymphatics. Thirty-three cases of LAM were reviewed retrospectively for clinical and radiologic findings. Twenty-eight (85%) of 33 women (aged 21–62 years; mean, 37.5 years) were symptomatic. Radiographs (n = 32) demonstrated reticular opacities in 21 (66%) patients, large lung volumes in 17 (53%), pleural effusion in 14 (44%), and pneumothorax in 13 (41%). High-resolution CT (n = 15) and conventional CT (n = 3) showed 2–5-mm bilateral thin-walled cysts in all patients and cysts that were 6–12 mm or larger in patients with severe lung involvement. CT depicted diffuse lung involvement by cysts in nine (50%) patients, relative sparing of lung apices in seven (39%), and relative sparing of lung bases in two (11%). Pleural effusion and pneumothorax were seen at CT in four (22%) and three (17%) patients, respectively. Four cases of tuberous sclerosis complex–associated LAM (TSC-LAM) (women aged 27–50 years; mean, 35.7 years) were similarly reviewed. Three (75%) were symptomatic. Radiographs (n = 4) demonstrated reticular opacities in three (75%) and large lung volumes in two (50%). All high-resolution CT (n = 3) and conventional CT (n = 1) studies showed 2–5-mm bilateral thin-walled cysts and cysts that were 6–12 mm or larger in two patients with severe lung involvement. Pleural effusion and pneumothorax were demonstrated at CT in three (75%) and two (50%) patients, respectively. LAM and TSC-LAM affect symptomatic women who often exhibit reticular opacities and large lung volumes at radiography and bilateral uniform small thin-walled cysts at CT. Large (>12 mm) cysts occur in patients with severe cystic lung involvement. Pneumothorax and pleural effusion are common associated findings.

References

  • 1 MüllerNL, Chiles C, Kullnig P. Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology1990; 175: 335–339.
  • 2 HancockE, Tomkins S, Sampson J, Osborne J. Lymphangioleiomyomatosis and tuberous sclerosis. Respir Med2002; 96: 7–13.
  • 3 KalassianKG, Doyle R, Kao P, Ruoss S, Raffin TA. Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med1997; 155: 1183–1186.
  • 4 KellyJ, Moss J. Lymphangioleiomyomatosis. Am J Med Sci2001; 321: 17–25.
  • 5 RosendalTR. A case of diffuse myomatosis and cyst formation in the lung. Acta Radiol1942; 23: 138–146.
  • 6 SullivanEJ. Lymphangioleiomyomatosis: a review. Chest1998; 114: 1689–1703.
  • 7 CornogJL Jr, Enterline HT. Lymphangiomyoma, a benign lesion of chyliferous lymphatics synonymous with lymphangiopericytoma. Cancer1966; 19: 1909–1930.
  • 8 JohnsonS. Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax1999; 54: 254–264.
  • 9 Pacheco-RodriguezG, Kristof AS, Stevens LA, et al. Genetics and gene expression in lymphangioleiomyomatosis. Chest2002; 121(3 suppl): 56S–60S.
  • 10 BittmannI, Rolf B, Amann G, Lohrs U. Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. Hum Pathol2003; 34: 95–98.
  • 11 CostelloLC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc2000; 75: 591–594.
  • 12 HancockE, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respir Med2002; 96: 1–6.
  • 13 UrbanT, Lazor R, Lacronique J, et al. Pulmonary lymphangioleiomyomatosis: a study of 69 patients. Medicine (Baltimore)1999; 78: 321–337.
  • 14 AubryMC, Myers JL, Ryu JH, et al. Pulmonary lymphangioleiomyomatosis in a man. Am J Respir Crit Care Med2000; 162(2 pt 1): 749–752.
  • 15 ChuSC, Horiba K, Usuki J, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest1999; 115: 1041–1052.
  • 16 FraserRS, Müller NL, Colman N, Paré PD. Hereditary abnormalities of pulmonary connective tissue. In: Fraser RS, Müller NL, Colman N, Paré PD, eds. Fraser and Paré’s diagnosis of diseases of the chest. 4th ed. Philadelphia, Pa: Saunders, 1999; 676–693.
  • 17 TravisWD, Colby TV, Koss MN, Rosado-de-Christenson ML, Müller NL, King TE Jr. Idiopathic interstitial pneumonia and diffuse parenchymal lung diseases. In: King DW, ed. Atlas of nontumor pathology: non-neoplastic disorders of the lower respiratory tract, fasc 2, ser 1. Washington, DC: American Registry of Pathology and Armed Forces Institute of Pathology, 2001; 49–231.
  • 18 TaylorJR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis: clinical course in 32 patients. N Engl J Med1990; 323: 1254–1260.
  • 19 Taveira-DaSilvaAM, Stylianou MP, Hedin CJ, et al. Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis. Am J Respir Crit Care Med2003; 168: 1427–1431.
  • 20 AberleDR, Hansell DM, Brown K, Tashkin DP. Lymphangiomyomatosis: CT, chest radiographic, and functional correlations. Radiology1990; 176: 381–387.
  • 21 AvilaNA, Kelly JA, Dwyer AJ, Johnson DL, Jones EC, Moss J. Lymphangioleiomyomatosis: correlation of qualitative and quantitative thin-section CT with pulmonary function tests and assessment of dependence on pleurodesis. Radiology2002; 223: 189–197.
  • 22 PacioccoG, Uslenghi E, Bianchi A, et al. Diffuse cystic lung diseases: correlation between radiologic and functional status. Chest2004; 125: 135–142.
  • 23 LuHC, Wang J, Tsang YM, Lin MC, Li YW. Lymphangioleiomyomatosis initially presenting with abdominal pain: a case report. Clin Imaging2003; 27: 166–170.
  • 24 JohnsonSR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax2000; 55: 1052–1057.
  • 25 AvilaNA, Bechtle J, Dwyer AJ, Ferrans VJ, Moss J. Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas. Radiology2001; 221: 415–421.
  • 26 MatsuiK, Tatsuguchi A, Valencia J, et al. Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. Hum Pathol2000; 31: 1242–1248.
  • 27 LamB, Ooi GC, Wong MP, et al. Extrapulmonary presentation of asymptomatic pulmonary lymphangioleiomyomatosis. Respirology2003; 8: 544–547.
  • 28 WongYY, Yeung TK, Chu WC. Atypical presentation of lymphangioleiomyomatosis as acute abdomen: CT diagnosis. AJR Am J Roentgenol2003; 181: 284–285.
  • 29 MaruyamaH, Ohbayashi C, Hino O, Tsutsumi M, Konishi Y. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2. Pathol Int2001; 51: 585–594.
  • 30 ShortM, Kwiatokowski DJ. Clinical and genetic aspects of tuberous sclerosis complex I and II. In: Moss J, ed. LAM and other diseases characterized by smooth muscle proliferation. Lung biology in health and disease, vol 131. New York, NY: Marcel Dekker, 1999; 387–406.
  • 31 JohnsonSR, Clelland CA, Ronan J, Tattersfield AE, Knox AJ. The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma. Histopathology2002; 40: 458–463.
  • 32 RyuJH. Tuberous sclerosis complex and LAM. In: Moss J, ed. LAM and other diseases characterized by smooth muscle proliferation. Lung biology in health and disease, vol 131. New York, NY: Marcel Dekker, 1999; 407–418.
  • 33 McCormackF, Brody A, Meyer C, et al. Pulmonary cysts consistent with lymphangioleiomyomatosis are common in women with tuberous sclerosis: genetic and radiographic analysis. Chest2002; 121(3 suppl): 61S.
  • 34 MossJ, Avila NA, Barnes PM, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med2001; 164: 669–671.
  • 35 CarsilloT, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A2000; 97: 6085–6090.
  • 36 KumasakaT, Seyama K, Mitani K, et al. Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis. Am J Surg Pathol2004; 28: 1007–1016.
  • 37 TravisWD, Usuki J, Horiba K, Ferrans VJ. Histopathologic studies on lymphangioleiomyomatosis. In: Moss J, ed. LAM and other diseases characterized by smooth muscle proliferation. Lung biology in health and disease, vol 131. New York, NY: Marcel Dekker, 1999; 171–217.
  • 38 CorrinB, Liebow AA, Friedman PJ. Pulmonary lymphangioleiomyomatosis: a review. Am J Pathol1975; 79: 348–382.
  • 39 ColbyTV, Carrington CB. Interstitial lung disease. In: Thurlbeck WM, Churg AM, eds. Pathology of the lung. 2nd ed. New York, NY: Thieme, 1995; 589–738.
  • 40 FukudaY. Ultrastructural pathology of pulmonary lymphangioleiomyomatosis. In: Moss J, ed. LAM and other diseases characterized by smooth muscle proliferation. Lung biology in health and disease, vol 131. New York, NY: Marcel Dekker, 1999; 219–239.
  • 41 GuineeD, Singh R, Azumi N, et al. Multifocal micronodular pneumocyte hyperplasia: a distinctive pulmonary manifestation of tuberous sclerosis. Mod Pathol1995; 8: 902–906.
  • 42 BonettiF, Chiodera PL, Pea M, et al. Transbronchial biopsy in lymphangiomyomatosis of the lung: HMB45 for diagnosis. Am J Surg Pathol1993; 17: 1092–1102.
  • 43 GuineeDG Jr, Feuerstein I, Koss MN, Travis WD. Pulmonary lymphangioleiomyomatosis: diagnosis based on results of transbronchial biopsy and immunohistochemical studies and correlation with high-resolution computed tomography findings. Arch Pathol Lab Med1994; 118: 846–849.
  • 44 SherrierRH, Chiles C, Roggli V. Pulmonary lymphangioleiomyomatosis: CT findings. AJR Am J Roentgenol1989; 153: 937–940.
  • 45 LenoirS, Grenier P, Brauner MW, et al. Pulmonary lymphangiomyomatosis and tuberous sclerosis: comparison of radiographic and thin-section CT findings. Radiology1990; 175: 329–334.
  • 46 DailDH. Uncommon tumors. In: Dail DH, Hammar SP, eds. Pulmonary pathology. 2nd ed. New York, NY: Springer-Verlag, 1994; 1279–1462.
  • 47 KitaichiM, Nishimura K, Itoh H, Izumi T. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med1995; 151: 527–533.
  • 48 LimKE, Tsai YH, Hsu Yl, Hsu WC. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings in 11 patients and compared with the literature. Clin Imaging2004; 28: 1–5.
  • 49 KirchnerJ, Stein A, Viel K, et al. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings. Eur Radiol1999; 9: 49–54.
  • 50 TempletonPA, McLoud TC, Müller NL, Shepard JA, Moore EH. Pulmonary lymphangioleiomyomatosis: CT and pathologic findings. J Comput Assist Tomogr1989; 13: 54–57.
  • 51 RappaportDC, Weisbrod GL, Herman SJ, Chamberlain DW. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings in four cases. AJR Am J Roentgenol1989; 152: 961–964.
  • 52 WebbWR, Müller NL, Naidich DP. Diseases characterized primarily by cysts and emphysema. In: Webb WR, Müller NL, Naidich DP, eds. High-resolution CT of the lung. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2001; 421–463.
  • 53 FraserRS, Müller NL, Colman N, Paré PD. Pleural effusion. In: Fraser RS, Müller NL, Colman N, Paré PD, eds. Fraser and Paré’s diagnosis of diseases of the chest. 4th ed. Philadelphia, Pa: Saunders, 1999; 2739–2794.
  • 54 CastroM, Shepherd CW, Gomez MR, Lie JT, Ryu JH. Pulmonary tuberous sclerosis. Chest1995; 107: 189–195.
  • 55 PallisaE, Sanz P, Roman A, Majo J, Andreu J, Caceres J. Lymphangioleiomyomatosis: pulmonary and abdominal findings with pathologic correlation. RadioGraphics2002; 22(Spec Issue): S185–S198.
  • 56 AbbottGF, Rosado-de-Christenson ML, Franks TJ, Frazier AA, Galvin JR. Pulmonary Langerhans cell histiocytosis. RadioGraphics2004; 24: 821–841.
  • 57 RyuJH, Doerr CH, Fisher SD, Olson EJ, Sahn SA. Chylothorax in lymphangioleiomyomatosis. Chest2003; 123: 623–627.
  • 58 BoehlerA, Speich R, Russi EW, Weder W. International survey on lung transplantation in lymphangioleiomyomatosis. In: Moss J, ed. LAM and other diseases characterized by smooth muscle proliferation. Lung biology in health and disease, vol 131. New York, NY: Marcel Dekker, 1999; 79–98.
  • 59 Taveira-DaSilvaAM, Stylianou MP, Hedin CJ, Hathaway O, Moss J. Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest2004; 126: 1867–1874.
  • 60 PechetTT, Meyers BF, Guthrie TJ, et al. Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant2004; 23: 301–308.
  • 61 KarbowniczekM, Astrinidis A, Balsara BR, et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med2003; 167: 976–982.
  • 62 CollinsJ, Müller NL, Kazerooni EA, McAdams HP, Leung AN, Love RB. Lung transplantation for lymphangioleiomyomatosis: role of imaging in the assessment of complications related to the underlying disease. Radiology1999; 210: 325–332.
  • 63 JohnsonSR, Whale CI, Hubbard RB, Lewis SA, Tattersfield AE. Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax2004; 59: 800–803.
  • 64 LazorR, Valeyre D, Lacronique J, Wallaert B, Urbane T, Cordier JF; the Groupe d’Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires. Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis. Respir Med2004; 98: 536–541.
  • 65 MatsuiK, Beasley MB, Nelson WK, et al. Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score. Am J Surg Pathol2001; 25: 479–484.

Article History

Published in print: May 2005